This compound is a tert-butyl carbamate derivative featuring a fluoropropyl-substituted azetidine ring. It is used as a pharmaceutical intermediate in the synthesis of active pharmaceutical ingredients.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 2222845-47-6
(R)-1-(1H-indazol-4-yl)propan-2-amine hydrochloride
pharmaceutical intermediate
1-(4-((3-chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-5-hydroxypyrrolidin-2-one (Afatinib Impurity)
pharmaceutical reference impurity
N1,N2-Bis(4-((3-chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)oxalamide
Pharmaceutical intermediate for Afatinib impurities
(S)-N1-(4-((3-CHLORO-4-FLUOROPHENYL)AMINO)-7-((TETRAHYDROFURAN-3-YL)OXY)QUINAZOLIN-6-YL)-N2,N2-DIMETHYLOXALAMIDE
pharmaceutical intermediate
Azetidine hydrochloride
Research reagent
Azétidine
pharmaceutical intermediate
(3-Fluoroazetidin-3-yl)methanol hydrochloride
pharmaceutical intermediate
3-Hydroxyazetidine hydrochloride
pharmaceutical intermediate
tert-butyl N-[1-(3-fluoropropyl)azetidin-3-yl]carbamate
DMVHTPKYWKOOPU-UHFFFAOYSA-N
CC(C)(C)OC(=O)NC1CN(C1)CCCF
—